Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients.
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
Combined structural and functional patterns discriminating upper limb motor disability in multiple sclerosis using multivariate approaches.
Subclinical myocardial dysfunction in multiple sclerosis patients remotely treated with mitoxantrone: evidence of persistent diastolic dysfunction.
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.
Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosis.
Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.
Mitoxantrone exerts both cytotoxic and immunoregulatory effects on activated microglial cells.
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
FDA Drug Safety Communication: FDA warns about case of rare brain infection PML with MS drug Tecfidera (dimethyl fumarate)
Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.
Rapid exacerbation of neuromyelitis optica after rituximab treatment.
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Risks of immune system treatments.
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis.
Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?
Site-Specific PEGylation Enhances the Pharmacokinetic Properties and Antitumor Activity of Interferon Beta-1b.
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis.
The Role of Endogenous IFN-β in the Regulation of Th17 Responses in Patients with Relapsing-Remitting Multiple Sclerosis.
Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.
Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience.
Interferon beta-1b-induced Sweet's syndrome in a patient with multiple sclerosis.
Dimethyl fumarate (BG-12, Tecfidera) - NICE gives initial "no" decision
Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage.

Pages